MAUI, Hawaii--()--The 2010 ROTH Fall Conference take place September 1 - 6, 2010 at the Grand Wailea Resort Hotel in Maui, Hawaii.
Business Wire is the official newswire for the 2010 ROTH Fall Conference. Breaking news releases, investor kits, and multimedia, are available at TradeshowNews.com, Business Wire's trade show, conference, and event news resource.
Presenter Profiles:
| Company: | China Integrated Energy | |
| Ticker Symbol & Exchange: | CBEH | |
| Investor Relations Contact: | Susan Zhou | |
| Investor Relations Contact Phone: | 305 393 5536 | |
| Web: | http://www.chinaintegratedenergy.com | |
| Date of Presentation: | SEPT. 3 | |
| China Integrated Energy, Inc. is a leading non-state-owned integrated energy company in China engaged in three business segments: the production and sale of biodiesel, the wholesale distribution of finished oil and heavy oil products, and the operation of retail gas stations. The Company operates a 100,000-ton biodiesel production plant with a goal of doubling capacity to 200,000 tons in 2010 through both internal expansion and an acquisition. The Company utilizes an extensive distribution network to distribute traditional petroleum products, and operates twelve retail gas stations in China. For additional information on the Company please visit http://www.chinaintegratedenergy.com. | ||
| Company: | Clarient, Inc. | |
| Ticker Symbol & Exchange: | CLRT | |
| Investor Relations Contact: | Matt Clawson | |
| Investor Relations Contact Phone: | 949/474-4300 | |
| Web: | www.clarientinc.com | |
| Date of Presentation: | SEPT. 3 | |
| Clarient combines diagnostic technologies with world-class pathology expertise to assess and characterize cancer. The rise of individualized medicine has created the need for a centralized resource that provides leading diagnostic technologies, such as molecular testing. Clarient is that resource. Employing advanced oncology testing and diagnostic technologies, diagnostic reports and analyses are made available to customers through Clarient’s Internet-based portal, PATHSiTE™. Clarient also plans to develop and market new, proprietary “companion” diagnostic markers for therapeutics in breast, prostate, lung and colon cancers, and leukemia and lymphoma. Clarient’s principal customers include pathologists, oncologists, hospitals and biopharmaceutical companies. www.clarientinc.com | ||
About Business Wire
Business Wire, a Berkshire Hathaway company, is utilized by tens of thousands of member companies and organizations worldwide to functionally enhance and communicate investor relations and public relations content to target audiences. As a recognized disclosure service in the United States, Canada and a dozen European countries, Business Wire facilitates the simultaneous flow of market-moving press releases from corporations to financial markets and their audiences, including regulatory authorities, media, investors, financial information systems and consumer news services. Business Wire also handles XBRL tagging, document formatting and regulatory filing into EDGAR, SEDAR, FSA and other systems.
Communications professionals turn to Business Wire to optimize and issue press releases, photos and multimedia to news organizations, journalists, trade publications, search engines, and individuals, with full-text posting to web sites, online services and databases. A range of distribution options enables members to target by geography, industry, news theme and audience demographics.
Founded in 1961, Business Wire has dual headquarters in San Francisco and New York, with 30 bureaus in cities including Los Angeles, Chicago, Boston, Miami, Paris, Frankfurt, London, Brussels, Tokyo, Toronto and Sydney and reciprocal offices throughout the world. Business Wire's patented NX data platform supports XML, XHTML and XBRL code that enhances news release interactivity, social media sharing and search engine optimization. More information about Business Wire and its services is located on its website at www.BusinessWire.com.

